Commit To Buy BioCryst Pharmaceuticals At $3, Earn 52.5% Annualized Using Options
January 23, 2017 at 11:50 AM EST
Investors considering a purchase of BioCryst Pharmaceuticals, Inc. (BCRX) stock, but tentative about paying the going market price of $5.90/share, might benefit from considering selling puts among the alternative strategies at their disposal..
